Liquidia Corporation (LQDA) vs Regencell Bioscience Holdings Limited (RGC)
- Liquidia Corporation LQDA 34.35 −1.24%
- Regencell Bioscience Holdings Limited RGC 9.59 +0.74%
Liquidia Corporation and Regencell Bioscience Holdings Limited are both Drug Manufacturers Specialty & Generic companies. Regencell Bioscience Holdings Limited is the larger, with a market value of $4.7B against $3.1B — 1.5× the size. Regencell Bioscience Holdings Limited has negative trailing earnings, so its P/E is not meaningful; Liquidia Corporation trades at 21.9×. Liquidia Corporation has the higher net margin (30.7% vs 0.00%) and the higher return on invested capital (121.1% vs 0.00%). Across the 12 metrics below, Liquidia Corporation leads on 10 and Regencell Bioscience Holdings Limited on 2.
Valuation
Profitability
| Metric | LQDA | RGC | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 92.54% | — | 53.94% |
| Operating margin | 37.39% | — | 0.00% |
| Net margin | 30.74% | 0.00% | 0.00% |
| Free cash flow margin | 33.42% | 0.00% | 0.00% |
| Return on equity | 131.82% | 0.00% | (0.40%) |
| Return on assets | 35.57% | 0.00% | (3.32%) |
| Return on invested capital | 121.05% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack